These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9593046)
21. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. Clevenger CV; Ngo W; Sokol DL; Luger SM; Gewirtz AM J Biol Chem; 1995 Jun; 270(22):13246-53. PubMed ID: 7768923 [TBL] [Abstract][Full Text] [Related]
22. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5). Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells. Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. McWhinney CD; Dostal D; Baker K J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424 [TBL] [Abstract][Full Text] [Related]
28. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991 [TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells. Murphy PR; Limoges M; Dodd F; Boudreau RT; Too CK Endocrinology; 2001 Jan; 142(1):81-8. PubMed ID: 11145569 [TBL] [Abstract][Full Text] [Related]
30. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma. Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425 [TBL] [Abstract][Full Text] [Related]
31. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18. Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853 [TBL] [Abstract][Full Text] [Related]
32. Prolactin receptor signaling: shared components with the T-cell antigen receptor in Nb2 lymphoma cells. Krumenacker JS; Montgomery DW; Buckley DJ; Gout PW; Buckley AR Endocrine; 1998 Dec; 9(3):313-20. PubMed ID: 10221598 [TBL] [Abstract][Full Text] [Related]
33. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element. Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725 [TBL] [Abstract][Full Text] [Related]
34. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin. Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136 [TBL] [Abstract][Full Text] [Related]
35. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. Lebrun JJ; Ali S; Sofer L; Ullrich A; Kelly PA J Biol Chem; 1994 May; 269(19):14021-6. PubMed ID: 8188682 [TBL] [Abstract][Full Text] [Related]
36. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754 [TBL] [Abstract][Full Text] [Related]
37. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells. Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321 [TBL] [Abstract][Full Text] [Related]
38. Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes. Roy B; Cathcart MK J Biol Chem; 1998 Nov; 273(48):32023-9. PubMed ID: 9822675 [TBL] [Abstract][Full Text] [Related]
39. Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Erwin RA; Kirken RA; Malabarba MG; Farrar WL; Rui H Endocrinology; 1995 Aug; 136(8):3512-8. PubMed ID: 7628388 [TBL] [Abstract][Full Text] [Related]
40. Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. Sorenson RL; Stout LE Endocrinology; 1995 Sep; 136(9):4092-8. PubMed ID: 7649117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]